Danaher Net Current Debt 2010-2025 | DHR

Danaher annual/quarterly net current debt history and growth rate from 2010 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
  • Danaher net current debt for the quarter ending March 31, 2025 was $1M, a 98.53% decline year-over-year.
  • Danaher net current debt for the twelve months ending March 31, 2025 was $-2.641B, a 68.54% increase year-over-year.
  • Danaher annual net current debt for 2024 was $-1.669B, a 2.64% increase from 2023.
  • Danaher annual net current debt for 2023 was $-1.626B, a 3.67% decline from 2022.
  • Danaher annual net current debt for 2022 was $-1.688B, a 174.53% decline from 2021.
Danaher Annual Net Current Debt
(Millions of US $)
2024 $-1,669
2023 $-1,626
2022 $-1,688
2021 $2,265
2020 $4,033
2019 $2,802
2018 $-508
2017 $1,114
2016 $760
2015 $3,511
2014 $-103
2013 $-763
2012 $196
2011 $854
2010 $N/A
2009 $-446
Sector Industry Market Cap Revenue
Medical Medical Services $143.850B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.468B 10.90
CVS Health (CVS) United States $83.959B 10.44
Cencora (COR) United States $56.658B 19.71
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.415B 0.00
Labcorp Holdings (LH) United States $21.653B 17.56
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.432B 0.00
Solventum (SOLV) United States $12.967B 13.73
CochLear (CHEOY) Australia $12.826B 0.00
ICON (ICLR) Ireland $11.783B 10.95
Revvity (RVTY) United States $11.516B 19.82
Viatris (VTRS) United States $10.434B 3.58
Avantor (AVTR) United States $9.254B 13.45
HealthEquity (HQY) United States $8.991B 39.38
Medpace Holdings (MEDP) United States $8.943B 23.75
Sonic Healthcare (SKHHY) Australia $8.181B 0.00
Charles River Laboratories (CRL) United States $7.378B 14.46
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.305B 25.35
BrightSpring Health Services (BTSG) United States $3.975B 36.47
Sotera Health (SHC) United States $3.162B 17.97
Surgery Partners (SGRY) United States $2.782B 36.18
Alignment Healthcare (ALHC) United States $2.710B 0.00
Concentras Parent (CON) United States $2.631B 15.21
Organon (OGN) United States $2.600B 2.76
GeneDx Holdings (WGS) United States $2.537B 97.72
PACS (PACS) United States $1.951B 0.00
Ardent Health (ARDT) United States $1.877B 8.00
Premier (PINC) United States $1.799B 13.66
Progyny (PGNY) United States $1.792B 39.45
GoodRx Holdings (GDRX) United States $1.754B 35.07
Teladoc Health (TDOC) United States $1.328B 0.00
Pediatrix Medical (MD) United States $1.171B 8.91
Establishment Labs Holdings (ESTA) $1.084B 0.00
CareDx (CDNA) United States $1.064B 16.62
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.902B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.806B 7.54
Nutex Health (NUTX) United States $0.670B 10.14
LifeMD (LFMD) United States $0.584B 0.00
Embecta (EMBC) United States $0.580B 3.91
InnovAge Holding (INNV) United States $0.516B 0.00
Enhabit (EHAB) United States $0.476B 39.17
Auna S.A (AUNA) Luxembourg $0.464B 10.45
Sonida Senior Living (SNDA) United States $0.455B 0.00
Omada Health (OMDA) $0.452B 0.00
SBC Medicals (SBC) United States $0.442B 0.00
Performant Healthcare (PHLT) United States $0.301B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.258B 0.00
Beauty Health (SKIN) United States $0.242B 0.00
Oncology Institute (TOI) United States $0.192B 0.00
So-Young (SY) China $0.189B 0.00
DocGo (DCGO) United States $0.165B 27.00
Pheton Holdings (PTHL) China $0.113B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.095B 0.00
KindlyMD (NAKA) United States $0.085B 0.00
Sera Prognostics (SERA) United States $0.075B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
ModivCare (MODV) United States $0.049B 0.00
Biodesix (BDSX) United States $0.040B 0.00
Basel Medical Group (BMGL) Singapore $0.038B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00